Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients
Korean J Hepatol. 2009;15(4):446-453. Published online 2009 Dec 31 DOI: https://doi.org/10.3350/kjhep.2009.15.4.446
Citations to this article as recorded by 
A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients
Bircan Kayaaslan, Esragul Akinci, Alpay Ari, Zeliha Kocak Tufan, Saygın Nayman Alpat, Ozgur Gunal, Selma Tosun, Rahmet Guner, Fehmi Tabak
Clinics and Research in Hepatology and Gastroenterology.2018; 42(1): 40. CrossRef
Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naïve patients with chronic hepatitis B: a multicenter real-life study
Ayse Batirel, Ertugrul Guclu, Ferhat Arslan, Funda Kocak, Oguz Karabay, Serdar Ozer, Munevver Turanli, Ali Mert
International Journal of Infectious Diseases.2014; 28: 153. CrossRef
Genotypic resistance to entecavir in chronic hepatitis B patients
Byeong Uk Kim, Ja Chung Goo, Byeong Chul Park, Soo Ok Kim, Sun Pyo Hong, Jee In Jeong, Hee Bok Chae, Seon Mee Park, Sei Jin Youn
The Korean Journal of Hepatology.2010; 16(2): 147. CrossRef
Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naïve patients with chronic hepatitis B
Hyung-Joon Myung, Sook-Hyang Jeong, Jin-Wook Kim, Hee-Sup Kim, Je-Hyuck Jang, Dong Ho Lee, Nayoung Kim, Jin-Hyeok Hwang, Young Soo Park, Sang-Hyub Lee
The Korean Journal of Hepatology.2010; 16(1): 57. CrossRef